Research Center of Translational Medicine, Central Hospital Affiliated to Shandong First Medical University, Jinan, China.
Research Center of Translational Medicine, Jinan Central Hospital, Shandong University, Jinan, China.
ESC Heart Fail. 2022 Oct;9(5):3167-3176. doi: 10.1002/ehf2.14042. Epub 2022 Jun 28.
Patients with congestive heart failure (CHF) may also suffer from chronic kidney disease (CKD), and the two conditions may interact to increase the risk of death. The purpose of this study was to investigate the risk factors contributing to in-hospital mortality in patients with CHF and CKD and to develop a nomogram to predict the risk of in-hospital mortality.
This retrospective study used data from the Marketplace for Medical Information in Intensive Care (MIMIC-IV, version 1.0). Patients diagnosed with CHF and CKD in MIMIC-IV were included in this study. The least absolute shrinkage and selection operator (LASSO) logistic regression is used to select risk variables for the nomogram model, and bootstrap is used for internal validation. Simplified Acute Physiology Score II (SAPS II) and Logistic Organ Dysfunction Score (LODS) were compared with the nomogram model by the area under the receiver operating characteristic curve (AUC) and decision curve analysis (DCA). A total of 4638 adult patients with CHF and CKD were included in the final cohort; of them, 707 (15.2%) died and 3931 (84.8%) survived during hospitalization. Our final model included the following 13 variables: age, acute kidney injury, myocardial infarction, anaemia, heart rate ≥ 100 b.p.m., systolic blood pressure ≥ 130 mmHg, anion gap (AG) ≥ 20 mEq/L, sodium ≥ 145 mEq/L, red blood cell distribution width (RDW) ≥ 15.5%, white blood cell count ≥ 10 K/μL, continuous renal replacement therapy (CRRT), angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, and beta-blocker. The corrected C-statistic of the nomogram was 0.767, and the calibration curve indicating good concordance between the predicted and observed values. The nomogram demonstrated good accuracy for predicting the in-hospital mortality with an AUC of 0.771 (95% CI: 0.752-0.790), while the AUC for SAPS II and LODS was 0.747 (95% CI: 0.726-0.767) and 0.752 (95% CI: 0.730-0.773), respectively. DCA found that when the threshold probability was 0.05 to 0.41, the nomogram model could provide a greater net benefit than SAPS II.
In this retrospective cohort analysis of patients with CHF and CKD, we identified 13 independent variables associated with in-hospital mortality using LASSO logistic regression. RDW, AG, and CRRT were reported to play a significant role in in-hospital mortality among patients with CHF and CKD for the first time. Based on a simplified model including 13 variables, a nomogram was drawn to predict the risk of in-hospital mortality. In comparison with SAPS II and LODS, the nomogram model performed well.
充血性心力衰竭(CHF)患者也可能患有慢性肾脏病(CKD),这两种疾病可能相互作用,增加死亡风险。本研究旨在探讨导致 CHF 和 CKD 患者住院期间死亡的危险因素,并开发一个列线图来预测住院期间死亡的风险。
本回顾性研究使用了 MarketPlace for Medical Information in Intensive Care(MIMIC-IV,版本 1.0)中的数据。将 MIMIC-IV 中诊断为 CHF 和 CKD 的患者纳入本研究。最小绝对收缩和选择算子(LASSO)逻辑回归用于选择列线图模型的风险变量,并用 bootstrap 进行内部验证。简化急性生理学评分 II(SAPS II)和逻辑器官功能障碍评分(LODS)通过接受者操作特征曲线(ROC)下面积(AUC)和决策曲线分析(DCA)与列线图模型进行比较。共纳入 4638 例成人 CHF 和 CKD 患者,其中 707 例(15.2%)死亡,3931 例(84.8%)存活。我们的最终模型包括以下 13 个变量:年龄、急性肾损伤、心肌梗死、贫血、心率≥100 b.p.m.、收缩压≥130mmHg、阴离子间隙(AG)≥20mEq/L、钠≥145mEq/L、红细胞分布宽度(RDW)≥15.5%、白细胞计数≥10K/μL、连续肾脏替代治疗(CRRT)、血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂和β受体阻滞剂。列线图的校正 C 统计量为 0.767,校准曲线表明预测值与观察值之间具有良好的一致性。该列线图在预测住院死亡率方面具有良好的准确性,AUC 为 0.771(95%CI:0.752-0.790),而 SAPS II 和 LODS 的 AUC 分别为 0.747(95%CI:0.726-0.767)和 0.752(95%CI:0.730-0.773)。DCA 发现,当阈值概率为 0.05 至 0.41 时,列线图模型比 SAPS II 能提供更大的净收益。
在这项对 CHF 和 CKD 患者的回顾性队列分析中,我们使用 LASSO 逻辑回归确定了与住院期间死亡率相关的 13 个独立变量。RDW、AG 和 CRRT 首次被报道在 CHF 和 CKD 患者的住院期间死亡率中发挥重要作用。基于包含 13 个变量的简化模型,绘制了一个列线图来预测住院期间死亡的风险。与 SAPS II 和 LODS 相比,该列线图模型表现良好。